Dog-rose, Cranberry leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in diabetes mellitus - Trial IRCT20220614055167N1
Access comprehensive clinical trial information for IRCT20220614055167N1 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Type 2 diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20220614055167N1
Phase 1/2
Recruiting
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT20220614055167N1
Dog-rose, Cranberry leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in diabetes mellitus
The Joint Effects of Dog-rose, Cranberry leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica, and Sumac for controlling blood glucose of patients with type II diabetes mellitus: A Phase 1-2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
Phase 1/2
Feb 28, 2023
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20220614055167N1
Non-Device Trial